Home Industries Market Insights About Us Publisher Contact us

Global Durvalumab Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031

ReportID: 710068

|

Published Date: 2024/07/06

|

No. of Pages: 165

|

Categories: Business & Financial Services

|

Format :

The report focuses on the Durvalumab market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Durvalumab market.

Major Players in the Durvalumab market are:

Medimmune (AstraZeneca)

On the basis of types, the Durvalumab market is primarily split into:

2.4mL Injection

10mL Injection

On the basis of applications, the market covers:

Locally Advanced Urothelial Carcinoma

Metastatic Urothelial Carcinoma

Other

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029
Global Durvalumab Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029

Chapter 1 Durvalumab Market Overview
1.1 Product Overview and Scope of Durvalumab
1.2 Durvalumab Market Segmentation by Type
1.2.1 Global Production Market Share of Durvalumab by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Durvalumab Market Segmentation by Application
1.3.1 Durvalumab Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Durvalumab Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Durvalumab (2014-2029)

Chapter 2 Global Economic Impact on Durvalumab Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Durvalumab Market Competition by Manufacturers
3.1 Global Durvalumab Production and Share by Manufacturers (2020 and 2022)
3.2 Global Durvalumab Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Durvalumab Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Durvalumab Manufacturing Base Distribution, Production Area and Product Type
3.5 Durvalumab Market Competitive Situation and Trends
3.5.1 Durvalumab Market Concentration Rate
3.5.2 Durvalumab Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Durvalumab Production, Revenue (Value) by Region (2014-2022)
4.1 Global Durvalumab Production by Region (2014-2022)
4.2 Global Durvalumab Production Market Share by Region (2014-2022)
4.3 Global Durvalumab Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Durvalumab Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Durvalumab Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Durvalumab Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Durvalumab Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Durvalumab Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Durvalumab Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Durvalumab Production, Revenue, Price and Gross Margin (2014-2022)

Chapter 5 Global Durvalumab Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Durvalumab Consumption by Regions (2014-2022)
5.2 North America Durvalumab Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Durvalumab Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Durvalumab Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Durvalumab Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Durvalumab Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Durvalumab Production, Consumption, Export, Import by Regions (2014-2022)

Chapter 6 Global Durvalumab Production, Revenue (Value), Price Trend by Type
6.1 Global Durvalumab Production and Market Share by Type (2014-2022)
6.2 Global Durvalumab Revenue and Market Share by Type (2014-2022)
6.3 Global Durvalumab Price by Type (2014-2022)
6.4 Global Durvalumab Production Growth by Type (2014-2022)

Chapter 7 Global Durvalumab Market Analysis by Application
7.1 Global Durvalumab Consumption and Market Share by Application (2014-2022)
7.2 Global Durvalumab Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Durvalumab Manufacturing Cost Analysis
8.1 Durvalumab Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Durvalumab

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Durvalumab Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Durvalumab Major Manufacturers in 2020
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global Durvalumab Market Forecast (2022-2029)
12.1 Global Durvalumab Production, Revenue Forecast (2022-2029)
12.2 Global Durvalumab Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Durvalumab Production Forecast by Type (2022-2029)
12.4 Global Durvalumab Consumption Forecast by Application (2022-2029)
12.5 Durvalumab Price Forecast (2022-2029)

Chapter 13 Appendix

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Price

Single User

US$3000

Multi User

US$4200

Corporate User

US$5100

Excel Datapack

US$1500

Download Sample Report

Kindly share your specific requirement (if any)
970580f357b66011f3ad9bfd8fd4652a.png

Global Durvalumab Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031